Worth Asset Management »

Iovance Biotherapeutics shares owned by Worth Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Worth Asset Management from 13F filings

Historical chart of Worth Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Worth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Worth Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $5.6k 800 7.04
2023-03-31 $3.1k 500 6.11
2022-12-31 $3.2k 500 6.39
2022-09-30 $5.0k 500 10.00
2022-06-30 $6.0k 500 12.00
2022-03-31 $6.0k 500 12.00

More positions owned by Worth Asset Management

Ishares Core 60/40 Balanced Allocation Etf Etf (AOR)
Invesco Qqq Trust Series I Etf (QQQ)
State Street Spdr Portfolio S&p 500 Etf Etf (SPLG)
Capital Group Core Balanced Etf Etf (CGBL)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Vanguard S&p 500 Etf Etf (VOO)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Vanguard Mega Cap Growth Etf Etf (MGK)
Apple Stock (AAPL)
Ishares Iboxx $ Investment Grade Corporate Bond Etf Etf (LQD)
Ishares 7-10 Year Treasury Bond Etf Etf (IEF)
Invesco Nasdaq 100 Etf Etf (QQQM)
Abrdn Physical Gold Shares Etf Etf (SGOL)
Vanguard Growth Etf Etf (VUG)
State Street Spdr S&p Biotech Etf Etf (XBI)

View all positions for Worth Asset Management

Top funds holding Iovance Biotherapeutics

MHR Fund Management
Vanguard Group
BlackRock
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Millennium Management
Dimensional Fund Advisors
Two Sigma Investments
Charles Schwab Investment Management

View all funds holding Iovance Biotherapeutics